Correlation Between Annexon and CytomX Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Annexon and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexon and CytomX Therapeutics, you can compare the effects of market volatilities on Annexon and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and CytomX Therapeutics.

Diversification Opportunities for Annexon and CytomX Therapeutics

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Annexon and CytomX is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Annexon i.e., Annexon and CytomX Therapeutics go up and down completely randomly.

Pair Corralation between Annexon and CytomX Therapeutics

Given the investment horizon of 90 days Annexon is expected to generate 0.58 times more return on investment than CytomX Therapeutics. However, Annexon is 1.73 times less risky than CytomX Therapeutics. It trades about 0.04 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  467.00  in Annexon on August 31, 2024 and sell it today you would earn a total of  73.00  from holding Annexon or generate 15.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Annexon  vs.  CytomX Therapeutics

 Performance 
       Timeline  
Annexon 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Annexon are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Annexon is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
CytomX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CytomX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, CytomX Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Annexon and CytomX Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Annexon and CytomX Therapeutics

The main advantage of trading using opposite Annexon and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.
The idea behind Annexon and CytomX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine